Notice ID: 399610ab88f94df4b4134535cd488d82Combined Synopsis/Solicitation
Animal Models and Retroviral Vaccines section (AMRVS) Retrovirus Assay, Reagent, and Viral Stock Preparation Support
Archived on January 31, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 10:00 AM UTC−05:00
- Posted
- January 26, 2024
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 541380: Testing Laboratories and Services
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NIH NCI
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- 75N91024Q00011
- Notice ID
- 399610ab88f94df4b4134535cd488d82
Description
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Vaccine Branch (VB), Retroviral Vaccines Branch (RVB), has a need for Laboratory Services for Immunological Assays, Virological Assays, Reagent and Viral Stock Preparation. This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, as supplemented with additional information included in this notice, and shall be processed in accordance with FAR 13.5 (Simplified Procedures for Certain Commercial Products and Commercial Services). This announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein. This solicitation is issued as a Request for Quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2024-06 (12/04/2023) The requirements North American Industry Classification System (NAICS) code is 541380 (Testing Laboratories and Services) with a size standard of $19.0 Million. One single award, the Indefinite Delivery Indefinite Quantity (IDIQ) award is anticipated to be made as a result of this solicitation. Amendment No.: A0002: The purpose of this amendment is to revise the inital Taks Orders (TO) estimated period of performance. All other RFQ information, terms, conditions, and due dates reamin unchanged. **Please see documents entitled "Amended_TaskOrder_SOW" for more details***
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N91024Q00011- Combined Synopsis
- 3×Combined SynopsisCurrentDec 7, 2023
Animal Models and Retroviral Vaccines section (AMRVS) Retrovirus Assay, Reagent, and Viral Stock Preparation Support
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N91024Q00011
Archive Date
Jan 31, 2024
Office Address
Bethesda, MD, 20892